These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 37686490)
1. Alternative Lengthening of Telomeres Is Rare in Canine Histiocytic Sarcoma. Kreilmeier-Berger T; Aupperle-Lellbach H; Reifinger M; Hörstke NV; Holzmann K; Kleiter M Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686490 [TBL] [Abstract][Full Text] [Related]
2. Alternative lengthening of telomeres does exist in various canine sarcomas. Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and potentially prognostic value of C-circles associated with alternative lengthening of telomeres in canine appendicular osteosarcoma. Bicanova L; Kreilmeier-Berger T; Reifinger M; Holzmann K; Kleiter M Vet Comp Oncol; 2021 Jun; 19(2):222-231. PubMed ID: 33211388 [TBL] [Abstract][Full Text] [Related]
4. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028 [TBL] [Abstract][Full Text] [Related]
5. Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies. Gocha AR; Nuovo G; Iwenofu OH; Groden J Am J Pathol; 2013 Jan; 182(1):41-8. PubMed ID: 23260199 [TBL] [Abstract][Full Text] [Related]
6. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT). De Vitis M; Berardinelli F; Sgura A Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031 [TBL] [Abstract][Full Text] [Related]
7. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies. Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780 [TBL] [Abstract][Full Text] [Related]
8. Reliable assessment of telomere maintenance mechanisms in neuroblastoma. Meeser A; Bartenhagen C; Werr L; Hellmann AM; Kahlert Y; Hemstedt N; Nürnberg P; Altmüller J; Ackermann S; Hero B; Simon T; Peifer M; Fischer M; Rosswog C Cell Biosci; 2022 Sep; 12(1):160. PubMed ID: 36153564 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of alternative lengthening of telomeres-associated biomarkers in uterine sarcoma and uterine carcinosarcoma. Lee YK; Park NH; Lee H Int J Gynecol Cancer; 2012 Mar; 22(3):434-41. PubMed ID: 22266933 [TBL] [Abstract][Full Text] [Related]
10. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta. Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461 [TBL] [Abstract][Full Text] [Related]
11. Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs. Thaiwong T; Sirivisoot S; Takada M; Yuzbasiyan-Gurkan V; Kiupel M Vet Comp Oncol; 2018 Jun; 16(2):220-228. PubMed ID: 28929581 [TBL] [Abstract][Full Text] [Related]
12. Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity. Sung JY; Lim HW; Joung JG; Park WY Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784588 [TBL] [Abstract][Full Text] [Related]
13. Morphological Distinction of Histiocytic Sarcoma from Other Tumor Types in Bernese Mountain Dogs and Flatcoated Retrievers. Erich SA; Constantino-Casas F; Dobson JM; Teske E In Vivo; 2018; 32(1):7-17. PubMed ID: 29275293 [TBL] [Abstract][Full Text] [Related]
14. Alternative Lengthening of Telomeres and Mediated Telomere Synthesis. Hou K; Yu Y; Li D; Zhang Y; Zhang K; Tong J; Yang K; Jia S Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565323 [TBL] [Abstract][Full Text] [Related]
15. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood. Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680 [TBL] [Abstract][Full Text] [Related]
16. A C-circle assay for detection of alternative lengthening of telomere activity in FFPE tissue. Idilli AI; Segura-Bayona S; Lippert TP; Boulton SJ STAR Protoc; 2021 Jun; 2(2):100569. PubMed ID: 34136834 [TBL] [Abstract][Full Text] [Related]
17. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism. Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957 [TBL] [Abstract][Full Text] [Related]
18. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549 [TBL] [Abstract][Full Text] [Related]
20. The telomere maintenance mechanism spectrum and its dynamics in gliomas. Kim S; Chowdhury T; Yu HJ; Kahng JY; Lee CE; Choi SA; Kim KM; Kang H; Lee JH; Lee ST; Won JK; Kim KH; Kim MS; Lee JY; Kim JW; Kim YH; Kim TM; Choi SH; Phi JH; Shin YK; Ku JL; Lee S; Yun H; Lee H; Kim D; Kim K; Hur JK; Park SH; Kim SK; Park CK Genome Med; 2022 Aug; 14(1):88. PubMed ID: 35953846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]